Download Citation
Article Source:
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Soldi R,
Ghosh Halder T,
Weston A,
Thode T,
Drenner K,
et al.
(2020)
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer.
PLOS ONE 15(7): e0235705.
https://doi.org/10.1371/journal.pone.0235705